Abbonarsi

Thyrotoxic periodic paralysis associated with lactic metabolic acidosis: Case report of an African man and review of literature - 14/07/23

Doi : 10.1016/j.ando.2023.01.007 
Maurine Allard a, , Mathilde Barrallier a, Hugo Pisaroni a, Mathilde Fichet a, Margot De La Vergne De Cerval a, Robin Pflaum a, Audrey Poisson a, Christèle Derrien a, Fabrice Bonnet a, Patricia Vaduva a
a Department of Endocrinology, University Hospital of Rennes, Rennes, France 

Corresponding author. CHU de Rennes, service d’endocrinologie, 16, boulevard de Bulgarie, 35000 Rennes, France.CHU de Rennes, service d’endocrinologie16, boulevard de BulgarieRennes35000France

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

Thyrotoxic periodic paralysis (TPP) is a rare and most often acquired subtype of hypokalemic periodic paralysis. The association of varying degrees of muscle weakness, hyperthyroidism and hypokalemia characterizes it. The treatment requires potassium supplementation, control of hyperthyroidism and prevention measures. It is a frequent disease in Asian men, but much rare in Caucasian or African populations. This is the first report of TPP associated with lactic metabolic acidosis in an African man.

Case presentation

A 23 year-old African man, native from Morocco, with recurrent episodes of tetraparesis for eleven months, and abdominal pain, was referred for evaluation. Biochemical investigations showed severe hypokalemia associated with hyperthyroidism and lactic metabolic acidosis. His EKG showed signs of hypokalemia such as sinus tachycardia and U waves. After potassium supplementation, neurological recuperation was quick and complete. Thyroid ultrasound identified a hypoechogenic and hypervascularized goiter, associated with high levels of thyroid antibodies, in favor of Grave's disease. With antithyroid drugs and life-style changes, the patient did not have any other attack.

Review of literature

In addition to the case report, this article presents an extended review of literature, from the first large study reporting the diagnosis and incidence of TPP in 1957 to nowadays. Are reported here the latest information concerning epidemiology, clinical manifestations, complementary examinations, management and genetic finding. The lactic acidosis observed initially is exceptional, never described in TPP. TPP is a diagnostic and therapeutic emergency, requiring careful potassium supplementation, in order to avoid the risk of the onset of rebound hyperkalemia, to be maintained until the etiological treatment is effective. Paraclinical assessment with emergency EKG and electromyogram are essential to assess the impact.

Discussion

It is essential in the face of any hypokalaemic periodic paralysis, including in non-Asian subjects, to search hyperthyroidism.

Conclusions

This report demonstrates the importance of thyroid testing in case of acute muscle weakness, even in non-Asian patients in order to diagnose TPP. This is a rare but possible etiology, to be distinguished from the familial form of hypokalemic periodic paralysis. It also questions on the impact of TPP on energetic metabolism, in particular on lactic metabolism.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Thyrotoxic periodic paralysis, TPP, Hypokalemic periodic paralysis, Paralysis, Thyrotoxicosis, Lactic acidosis, HPP, Periodic paralysis

Abbreviations : CACNA1S, EKG, EMG, FHPP, HPP, KCNJ18, SCN4A, SNPs, T3, T4, TPP, TSH


Mappa


© 2023  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 84 - N° 4

P. 440-445 - agosto 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients
  • Victor Vermot-Desroches, Kim Thia-Soui-Tchong, Perrine Raymond, Andrea Filip, Jacques Orgiazzi, Emmanuel Jouanneau, Caroline Froment Tilikete, Françoise Borson-Chazot, Romain Manet, Juliette Abeillon Du Payrat
| Articolo seguente Articolo seguente
  • Dual-phase computed tomography for localization of parathyroid lesions in children and adolescents with primary hyperparathyroidism
  • Anima Sharma, Virendra Patil, Vijaya Sarathi, Nilendu Purandare, Priya Hira, Saba Memon, Swati S. Jadhav, Manjiri Karlekar, Anurag R. Lila, Tushar Bandgar

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.